Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G
- PMID: 15269786
- PMCID: PMC479043
- DOI: 10.1371/journal.pbio.0020275
Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G
Abstract
Host genomes have adopted several strategies to curb the proliferation of transposable elements and viruses. A recently discovered novel primate defense against retroviral infection involves a single-stranded DNA-editing enzyme, APOBEC3G, that causes hypermutation of HIV. The HIV-encoded virion infectivity factor (Vif) protein targets APOBEC3G for destruction, setting up a genetic conflict between the APOBEC3G and Vif genes. This kind of conflict leads to rapid fixation of mutations that alter amino acids at the protein-protein interface, referred to as positive selection. We show that the APOBEC3G gene has been subject to strong positive selection throughout the history of primate evolution. Unexpectedly, this selection appears more ancient than, and is likely only partially caused by, modern lentiviruses. Furthermore, five additional APOBEC genes in the human genome appear to be engaged in similar genetic conflicts, displaying some of the highest signals for positive selection in the human genome. Despite being only recently discovered, editing of RNA and DNA may thus represent an ancient form of host defense in primate genomes.
Conflict of interest statement
The authors have declared that no conflicts of interest exist.
Figures
Similar articles
-
APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.Med Sci Monit. 2006 May;12(5):RA92-8. Med Sci Monit. 2006. PMID: 16641889 Review.
-
Rapid evolution of primate antiviral enzyme APOBEC3G.Hum Mol Genet. 2004 Aug 15;13(16):1785-91. doi: 10.1093/hmg/ddh183. Epub 2004 Jun 15. Hum Mol Genet. 2004. PMID: 15198990
-
Population level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation.J Virol. 2006 Sep;80(18):9259-69. doi: 10.1128/JVI.00888-06. J Virol. 2006. PMID: 16940537 Free PMC article.
-
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.Nature. 2003 Jul 3;424(6944):99-103. doi: 10.1038/nature01709. Epub 2003 May 28. Nature. 2003. PMID: 12808466
-
[The innate antiretroviral defense of human cells, based on the DNA editing].Postepy Biochem. 2006;52(3):247-52. Postepy Biochem. 2006. PMID: 17201059 Review. Polish.
Cited by
-
Lineage-specific evolution of T-cell immunoglobulin and mucin domain 1 gene in the primates.Immunogenetics. 2012 Sep;64(9):669-78. doi: 10.1007/s00251-012-0628-y. Epub 2012 Jun 19. Immunogenetics. 2012. PMID: 22710823
-
Counteraction of tetherin antiviral activity by two closely related SIVs differing by the presence of a Vpu gene.PLoS One. 2012;7(4):e35411. doi: 10.1371/journal.pone.0035411. Epub 2012 Apr 17. PLoS One. 2012. PMID: 22530020 Free PMC article.
-
The von Hippel-Lindau Cullin-RING E3 ubiquitin ligase regulates APOBEC3 cytidine deaminases.Transl Res. 2021 Nov;237:1-15. doi: 10.1016/j.trsl.2021.05.002. Epub 2021 May 15. Transl Res. 2021. PMID: 34004371 Free PMC article.
-
How SAMHD1 changes our view of viral restriction.Trends Immunol. 2012 Jan;33(1):26-33. doi: 10.1016/j.it.2011.11.002. Epub 2011 Dec 15. Trends Immunol. 2012. PMID: 22177690 Free PMC article. Review.
-
Retroelements versus APOBEC3 family members: No great escape from the magnificent seven.Front Microbiol. 2012 Aug 14;3:275. doi: 10.3389/fmicb.2012.00275. eCollection 2012. Front Microbiol. 2012. PMID: 22912627 Free PMC article.
References
-
- Anisimova M, Bielawski JP, Yang Z. Accuracy and power of Bayes prediction of amino acid sites under positive selection. Mol Biol Evol. 2002;19:950–958. - PubMed
-
- Chan L, Chang BHJ, Nakamuta M, Li WH, Smith LC. Apobec-1 and apolipoprotein B mRNA editing. Biochim Biophys Acta. 1997;1345:11–26. - PubMed
-
- Comeron JM. K-estimator: Calculation of the number of nucleotide substitutions per site and the confidence intervals. Bioinformatics. 1999;15:763–764. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
